Home > Insider Trading > Filing (0000899243-19-006155)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
730272	Repligen Corp	RGEN	Biological Products, (No Disgnostic Substances) (2836)	042729386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1613498	Jon Snodgres	C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-03-01	4,700	$0.00	29,646	No	4	A	Direct
Common Stock	Disposition	2019-03-05	2,645	$58.52	27,001	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents shares awarded pursuant to Performance Share Units ("PSUs"). The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria related to the filing of the 2018 Annual Report on Form 10-K, which was filed on March 1, 2019. These PSUs vested on March 1, 2019.
Sale of 2,645 shares in the open market to cover tax liability resulting from the release of restricted stock units and PSUs.
$58.52 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.28 to $58.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.